NGL Fine-Chem Limited
NGLFINE.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.07B
Close$
$-2786.65
200.5% downside
Current Fair Value
200.5% downsideOvervalued by 200.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $18.07 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $1.75 (0.06%) |
| Earnings per Share | $77.9 |
| Beta | 0.88 |
| Outstanding Shares | 6,178,024 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 31.59 |
|---|---|
| PEG | 31.88 |
| Price to Sales | 3.2 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About NGL Fine-Chem Limited
502 employees
CEO: Rahul Jayant Nachane NGL Fine-Chem Limited operates as a global developer and purveyor of pharmaceutical products and chemical intermediates, catering to both the animal and human health industries. The company's extensive offerings include a broad spectrum ...